Azitra (AZTR) EPS (Diluted) (2022 - 2026)

Azitra (AZTR) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Nanobiotix 1,769.80 Bn 1,769.74 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 0.00
3 BeOne Medicines 473.64 Bn 468.85 Bn 1.35 Bn 0.15
4 Vertex Pharmaceuticals 123.74 Bn 116.49 Bn 2.59 Bn 4.02
5 Regeneron Pharmaceuticals 71.73 Bn 62.97 Bn 3.31 Bn 6.75
6 Belite Bio 62.10 Bn 62.10 Bn - 0.00
7 Argenx Se 54.68 Bn 49.49 Bn 1.41 Bn 7.33
8 Alnylam Pharmaceuticals 38.13 Bn 35.12 Bn 959.66 Mn 1.49
9 Revolution Medicines 36.21 Bn 36.21 Bn - -2.29
10 Azitra 2.03 Mn 2.03 Mn - -0.25

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.25
Dec 31, 2025 -0.46
Sep 30, 2025 -0.67
Jun 30, 2025 -1.18
Mar 31, 2025 -1.55
Dec 31, 2024 -4.21
Sep 30, 2024 -1.16
Jun 30, 2024 -18.26
Mar 31, 2024 -29.04
Dec 31, 2023 -70.81
Sep 30, 2023 -32.10
Jun 30, 2023 -472.02
Mar 31, 2023 -600.01
Dec 31, 2022 -897.16
Sep 30, 2022 -588.77
Jun 30, 2022 -488.91